References
Ntentakis DP, Correa VSMC, Ntentaki AM, Delavogia E, Narimatsu T, Efstathiou NE, Vavvas DG (2023) Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-023-06236-5
Lahoti S, Nashawi M, Sheikh O, Massop D, Mir M, Chilton R (2020) Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond. Cardiovasc Endocrinol Metab 10(1):3–13. https://doi.org/10.1097/XCE.0000000000000209
Nadelmann JB, Miller CG, McGeehan B, Yu Y, VanderBeek BL (2023) SGLT2 inhibitors and diabetic retinopathy progression. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-023-06273-0
Sharma A, Parachuri N, Kumar N, Saboo B, Tripathi HN, Kuppermann BD, Bandello F (2022) Semaglutide and the risk of diabetic retinopathy-current perspective. Eye (Lond) 36(1):10–11. https://doi.org/10.1038/s41433-021-01741-5
Hebsgaard JB, Pyke C, Yildirim E, Knudsen LB, Heegaard S, Kvist PH (2018) Glucagon-like peptide-1 receptor expression in the human eye. Diabetes Obes Metab 20(9):2304–2308. https://doi.org/10.1111/dom.13339.9507
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None — SJ is a consultant ophthalmologist leading a regional retinopathy screening service and treating patients with diabetic retinopathy, and GIV is a consultant physician managing patients with diabetes mellitus–related complications.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jacob, S., Varughese, G.I. The temporal trends in association between newer medications and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 262, 1369–1370 (2024). https://doi.org/10.1007/s00417-023-06357-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-023-06357-x